Zélia M. Corrêa

3.1k total citations
127 papers, 1.4k citations indexed

About

Zélia M. Corrêa is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Zélia M. Corrêa has authored 127 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Ophthalmology, 37 papers in Oncology and 32 papers in Molecular Biology. Recurrent topics in Zélia M. Corrêa's work include Ocular Oncology and Treatments (85 papers), Retinal Development and Disorders (24 papers) and Retinal Diseases and Treatments (22 papers). Zélia M. Corrêa is often cited by papers focused on Ocular Oncology and Treatments (85 papers), Retinal Development and Disorders (24 papers) and Retinal Diseases and Treatments (22 papers). Zélia M. Corrêa collaborates with scholars based in United States, Brazil and Canada. Zélia M. Corrêa's co-authors include James J. Augsburger, Adeel H. Shaikh, Rupak K. Banerjee, Miguel N. Burnier, Ítalo Mundialino Marcon, Alexandre Nakao Odashiro, J. William Harbour, Christopher J. Rapuano, Zubair M. Ahmed and James I. Geller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Zélia M. Corrêa

112 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zélia M. Corrêa United States 21 1.1k 430 424 324 185 127 1.4k
Junna Oba Japan 12 233 0.2× 278 0.6× 227 0.5× 45 0.1× 189 1.0× 24 640
Marko Määttã Finland 17 180 0.2× 202 0.5× 94 0.2× 282 0.9× 67 0.4× 28 835
Sarah E. Nicholas United States 15 103 0.1× 172 0.4× 224 0.5× 276 0.9× 159 0.9× 38 807
Catalin Mihalcioiu Canada 14 65 0.1× 391 0.9× 422 1.0× 47 0.1× 155 0.8× 38 1000
Matthew J. Cecchini Canada 19 74 0.1× 691 1.6× 491 1.2× 70 0.2× 121 0.7× 69 1.3k
Kirsi Hämäläinen Finland 17 64 0.1× 468 1.1× 294 0.7× 130 0.4× 211 1.1× 32 1.0k
Shinji Ozaki Japan 19 68 0.1× 252 0.6× 256 0.6× 204 0.6× 50 0.3× 77 1.0k
Kai Ding China 19 52 0.0× 641 1.5× 222 0.5× 63 0.2× 242 1.3× 72 1.2k
Yoshiko Matsumoto Japan 16 43 0.0× 382 0.9× 194 0.5× 43 0.1× 231 1.2× 39 897
Barbara Withers Australia 16 128 0.1× 177 0.4× 242 0.6× 74 0.2× 199 1.1× 36 849

Countries citing papers authored by Zélia M. Corrêa

Since Specialization
Citations

This map shows the geographic impact of Zélia M. Corrêa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zélia M. Corrêa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zélia M. Corrêa more than expected).

Fields of papers citing papers by Zélia M. Corrêa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zélia M. Corrêa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zélia M. Corrêa. The network helps show where Zélia M. Corrêa may publish in the future.

Co-authorship network of co-authors of Zélia M. Corrêa

This figure shows the co-authorship network connecting the top 25 collaborators of Zélia M. Corrêa. A scholar is included among the top collaborators of Zélia M. Corrêa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zélia M. Corrêa. Zélia M. Corrêa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dollar, James J., Vasileios Stathias, Shaun P. Brothers, et al.. (2025). Identification of targetable epigenetic vulnerabilities for uveal melanoma. Cell Death and Disease. 17(1). 89–89.
2.
3.
Augsburger, James J., et al.. (2024). Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice. Clinical ophthalmology. Volume 18. 3103–3109. 1 indexed citations
4.
Lutzky, Jose, Lynn G. Feun, Zélia M. Corrêa, et al.. (2024). 1126P A phase II study of nivolumab/relatlimab in metastatic uveal melanoma. Annals of Oncology. 35. S741–S741. 2 indexed citations
5.
6.
Castela, Guilherme, Bárbara Oliveiros, Sónia Silva, et al.. (2023). Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting. Clinical ophthalmology. Volume 17. 487–496. 3 indexed citations
7.
Kurtenbach, Stefan, Margaret I. Sanchez, Daniel A. Rodriguez, et al.. (2023). PRAME induces genomic instability in uveal melanoma. Oncogene. 43(8). 555–565. 13 indexed citations
8.
Williams, Basil K., Sudhakar Vadivelu, Zélia M. Corrêa, et al.. (2022). Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. Pediatric Blood & Cancer. 70(2). e30071–e30071. 7 indexed citations
9.
Augsburger, James J., et al.. (2022). Comparative Metastatic Rates in GEP Class 1A versus 1B Posterior Uveal Melanoma: Results Contrary to Expectations. Ocular Oncology and Pathology. 8(4-6). 242–249. 5 indexed citations
10.
Gallo, Ryan A., et al.. (2022). Early Mechanisms of Chemoresistance in Retinoblastoma. Cancers. 14(19). 4966–4966. 10 indexed citations
11.
Dollar, James J., Margaret I. Sanchez, Christina L. Decatur, et al.. (2022). BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas. Cancers. 14(15). 3678–3678. 23 indexed citations
12.
Castela, Guilherme, et al.. (2021). Treatment of Advanced Retinoblastoma in Children Evacuated from Low-Income Countries: Experience from a National Referral Center in Portugal. Clinical ophthalmology. Volume 15. 4765–4773. 1 indexed citations
13.
Pinedo, Miguel, et al.. (2021). A Qualitative View of Migration-Related Stressors on the Mental Health of Latinx Americans in the Current Sociopolitical Climate of Hostility Towards Migrants. Journal of Immigrant and Minority Health. 23(5). 1053–1064. 13 indexed citations
14.
Augsburger, James J., et al.. (2020). Isolated choroidal melanocytosis: clinical update on 37 cases. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(12). 2819–2829. 6 indexed citations
15.
Liu, T. Y. Alvin, J. Fernando Arévalo, Ferdinand Hui, et al.. (2020). Gene Expression Profile Prediction in Uveal Melanoma Using Deep Learning. Ophthalmology Retina. 4(12). 1213–1215. 11 indexed citations
16.
Karim, Nagla Abdel, et al.. (2018). GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome. Case Reports in Oncological Medicine. 2018. 1–5. 7 indexed citations
17.
Abruzzo, Todd, et al.. (2014). Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy. Journal of NeuroInterventional Surgery. 7(10). 770–776. 20 indexed citations
18.
Augsburger, James J. & Zélia M. Corrêa. (2011). Expected Long-term Survival Prognosis Of Posterior Uveal Melanoma Patients Whose Tumor Cells Exhibit Disomy 3 And/or Class 1 Gene Expression Profile. Investigative Ophthalmology & Visual Science. 52(14). 1433–1433.
19.
Corrêa, Zélia M., et al.. (2011). Toxicity of a Biodegradable Microneedle Implant Loaded with Methotrexate as a Sustained Release Device in Normal Rabbit Eye: A Pilot Study. Journal of Ocular Pharmacology and Therapeutics. 27(2). 151–156. 37 indexed citations
20.
Shaikh, Adeel H., Zélia M. Corrêa, & James J. Augsburger. (2008). Relationship Between Reese-Ellsworth Classification and International Classification of Intraocular Retinoblastoma. Investigative Ophthalmology & Visual Science. 49(13). 13–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junna Oba Breakdown of academic impact, for papers by Marko Määttã Breakdown of academic impact, for papers by Sarah E. Nicholas Breakdown of academic impact, for papers by Catalin Mihalcioiu Breakdown of academic impact, for papers by Matthew J. Cecchini Breakdown of academic impact, for papers by Kirsi Hämäläinen Breakdown of academic impact, for papers by Shinji Ozaki Breakdown of academic impact, for papers by Kai Ding Breakdown of academic impact, for papers by Yoshiko Matsumoto Breakdown of academic impact, for papers by Barbara Withers
Rankless by CCL
2026